Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2523

TDMS Study 05080-01 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                        ALLYL GLYCIDYL ETHER


NTP Experiment-Test: 05080-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/10/94
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04




       Facility:  Battelle Northwest

       Chemical CAS #:  106-92-3

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS FEMALE                CONTROL      5 PPM        10 PPM                                                 
                                                   FEMALE       FEMALE       FEMALE                                                 
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Dead                                               9            8            5                                                  
    Moribund                                          17           12           20                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                24           30           25                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (47)         (50)         (49)                                                
      Acanthosis                                       1 (2%)                                                                       
      Hyperkeratosis                                   1 (2%)                                                                       
      Inflammation, Chronic                            1 (2%)                                                                       
   Intestine Large, Cecum                             (34)         (35)         (38)                                                
      Granuloma                                                                  1 (3%)                                             
      Hemorrhage                                                    1 (3%)                                                          
      Inflammation                                                               1 (3%)                                             
      Parasite Metazoan                                3 (9%)       2 (6%)       3 (8%)                                             
   Intestine Large, Colon                             (45)         (45)         (46)                                                
      Inflammation, Suppurative                        1 (2%)       1 (2%)                                                          
      Necrosis                                                      1 (2%)                                                          
      Parasite Metazoan                                4 (9%)       2 (4%)       5 (11%)                                            
      Ulcer                                                         1 (2%)                                                          
   Intestine Large, Rectum                            (46)         (45)         (43)                                                
      Hyperplasia, Lymphoid                                         1 (2%)                                                          
      Parasite Metazoan                                2 (4%)       3 (7%)                                                          
   Intestine Small, Jejunum                           (41)         (43)         (44)                                                
      Inflammation, Suppurative                        1 (2%)                                                                       
      Muscularis, Hyperplasia                          1 (2%)                                                                       
   Liver                                              (50)         (48)         (49)                                                
      Angiectasis                                      1 (2%)       3 (6%)       3 (6%)                                             
      Basophilic Focus                                              2 (4%)                                                          
      Basophilic Focus, Multiple                                    1 (2%)                                                          
      Clear Cell Focus                                 1 (2%)       1 (2%)       2 (4%)                                             
      Developmental Malformation                                    1 (2%)       1 (2%)                                             
      Eosinophilic Focus                               3 (6%)       1 (2%)                                                          
      Hematopoietic Cell Proliferation                 7 (14%)      4 (8%)       3 (6%)                                             
      Inflammation, Suppurative                                                  1 (2%)                                             
      Leukocytosis                                     1 (2%)                    1 (2%)                                             
      Necrosis                                         2 (4%)       3 (6%)       3 (6%)                                             
      Vacuolization Cytoplasmic                        2 (4%)                                                                       
      Bile Duct, Cyst                                  1 (2%)                    1 (2%)                                             
      Bile Duct, Hyperplasia                           1 (2%)       3 (6%)       2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS FEMALE                CONTROL      5 PPM        10 PPM                                                 
                                                   FEMALE       FEMALE       FEMALE                                                 
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hepatocyte, Cytomegaly                                        1 (2%)                                                          
   Mesentery                                                       (1)          (3)                                                 
      Artery, Inflammation                                          1 (100%)     1 (33%)                                            
   Pancreas                                           (50)         (48)         (49)                                                
      Atrophy                                          1 (2%)       3 (6%)       2 (4%)                                             
      Inflammation, Chronic                                                      1 (2%)                                             
      Acinus, Hyperplasia                                           2 (4%)                                                          
      Artery, Inflammation                                          1 (2%)       5 (10%)                                            
   Pharynx                                            (2)                                                                           
      Necrosis                                         1 (50%)                                                                      
      Ulcer                                            1 (50%)                                                                      
      Epithelium, Hyperplasia                          1 (50%)                                                                      
      Palate, Ulcer                                    1 (50%)                                                                      
   Salivary Glands                                    (48)         (47)         (48)                                                
      Inflammation, Chronic                            1 (2%)                    1 (2%)                                             
      Inflammation, Suppurative                        1 (2%)                                                                       
      Karyomegaly                                      4 (8%)       1 (2%)       2 (4%)                                             
   Stomach, Forestomach                               (50)         (47)         (46)                                                
      Acanthosis                                       1 (2%)       3 (6%)       2 (4%)                                             
      Hyperkeratosis                                                             1 (2%)                                             
      Perforation                                                   1 (2%)                                                          
   Stomach, Glandular                                 (50)         (48)         (44)                                                
      Erosion                                                                    1 (2%)                                             
      Hyperplasia                                                   1 (2%)                                                          
      Inflammation, Suppurative                                                  1 (2%)                                             
      Mineralization                                   1 (2%)       2 (4%)       2 (5%)                                             
   Tooth                                              (1)          (1)                                                              
      Inflammation, Suppurative                                     1 (100%)                                                        
      Incisor, Developmental Malformation              1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (49)         (50)                                                
      Cardiomyopathy                                   7 (14%)      4 (8%)       5 (10%)                                            
      Embolus Bacterial                                1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)       1 (2%)       1 (2%)                                             
      Artery, Mineralization                                        1 (2%)       1 (2%)                                             
      Atrium, Thrombosis                               2 (4%)                                                                       
      Myocardium, Mineralization                                                 1 (2%)                                             
      Myocardium, Necrosis                                                       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS FEMALE                CONTROL      5 PPM        10 PPM                                                 
                                                   FEMALE       FEMALE       FEMALE                                                 
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (49)         (49)                                                
      Angiectasis                                     30 (60%)     36 (73%)     22 (45%)                                            
      Angiectasis, Multiple                            1 (2%)                                                                       
      Atrophy                                                                    1 (2%)                                             
      Cyst                                             1 (2%)                                                                       
      Hemorrhage                                       1 (2%)                    1 (2%)                                             
      Hyperplasia                                     16 (32%)     11 (22%)     12 (24%)                                            
      Necrosis                                                      1 (2%)                                                          
      Vacuolization Cytoplasmic                       13 (26%)     11 (22%)      9 (18%)                                            
   Adrenal Gland, Medulla                             (49)         (48)         (47)                                                
      Hematopoietic Cell Proliferation                 1 (2%)                                                                       
      Hyperplasia                                      8 (16%)     10 (21%)      4 (9%)                                             
      Hyperplasia, Multiple                                         2 (4%)                                                          
   Parathyroid Gland                                  (26)         (32)         (33)                                                
      Hyperplasia                                      1 (4%)                                                                       
   Pituitary Gland                                    (50)         (45)         (48)                                                
      Hemorrhage                                                                 1 (2%)                                             
      Pars Distalis, Cyst                              1 (2%)       2 (4%)                                                          
      Pars Distalis, Hyperplasia                       4 (8%)                    5 (10%)                                            
   Thyroid Gland                                      (49)         (47)         (47)                                                
      Ultimobranchial Cyst                             4 (8%)       9 (19%)      4 (9%)                                             
      C-Cell, Hyperplasia                             10 (20%)     12 (26%)     10 (21%)                                            
      Follicular Cell, Cyst                            1 (2%)       1 (2%)                                                          
      Follicular Cell, Hyperplasia                     2 (4%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (43)         (45)         (43)                                                
      Cyst                                             6 (14%)     12 (27%)     14 (33%)                                            
      Cyst, Multiple                                                1 (2%)                                                          
      Inflammation, Suppurative                       15 (35%)     13 (29%)     15 (35%)                                            
   Ovary                                              (49)         (48)         (49)                                                
      Cyst                                             4 (8%)      10 (21%)      8 (16%)                                            
      Inflammation, Suppurative                        1 (2%)       1 (2%)                                                          
      Capsule, Hyperplasia                                                       1 (2%)                                             
   Uterus                                             (50)         (50)         (50)                                                
      Inflammation, Suppurative                        7 (14%)      1 (2%)       3 (6%)                                             
      Thrombosis                                                                 1 (2%)                                             
      Artery, Inflammation                                                       1 (2%)                                             
      Endometrium, Hyperplasia                        14 (28%)     22 (44%)     12 (24%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS FEMALE                CONTROL      5 PPM        10 PPM                                                 
                                                   FEMALE       FEMALE       FEMALE                                                 
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Endometrium, Metaplasia, Squamous                2 (4%)       5 (10%)      6 (12%)                                            
      Lumen, Dilatation                                2 (4%)       4 (8%)       3 (6%)                                             
      Lumen, Hemorrhage                                             2 (4%)       1 (2%)                                             
      Wall, Necrosis                                                1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (45)         (48)                                                
      Atrophy                                          4 (8%)                                                                       
   Lymph Node                                         (48)         (50)         (49)                                                
      Mesenteric, Hemorrhage                                        1 (2%)                                                          
      Renal, Hyperplasia, Lymphoid                                  1 (2%)                                                          
   Lymph Node, Bronchial                              (34)         (39)         (43)                                                
      Fibrosis                                                                   1 (2%)                                             
      Hemorrhage                                       1 (3%)       1 (3%)       1 (2%)                                             
   Lymph Node, Mandibular                             (43)         (45)         (44)                                                
      Hemorrhage                                                    2 (4%)                                                          
      Hyperplasia, Lymphoid                                         1 (2%)       1 (2%)                                             
   Spleen                                             (50)         (48)         (49)                                                
      Cyst                                                                       1 (2%)                                             
      Hematopoietic Cell Proliferation                 6 (12%)      5 (10%)      8 (16%)                                            
      Artery, Inflammation                                                       1 (2%)                                             
   Thymus                                             (41)         (47)         (43)                                                
      Cyst                                                          4 (9%)                                                          
      Inflammation, Suppurative                                     1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)                                                
      Cyst                                             1 (2%)                                                                       
      Galactocele                                      2 (4%)       1 (2%)       1 (2%)                                             
      Inflammation, Suppurative                        2 (4%)       1 (2%)                                                          
   Skin                                               (48)         (49)         (49)                                                
      Acanthosis                                                                 2 (4%)                                             
      Cyst Epithelial Inclusion                                                  1 (2%)                                             
      Hyperkeratosis                                                             1 (2%)                                             
      Inflammation, Suppurative                        1 (2%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (49)         (49)         (50)                                                
      Fibrous Osteodystrophy                                        1 (2%)       1 (2%)                                             
      Osteopetrosis                                                              1 (2%)                                             
      Cranium, Necrosis                                1 (2%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS FEMALE                CONTROL      5 PPM        10 PPM                                                 
                                                   FEMALE       FEMALE       FEMALE                                                 
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (49)         (50)         (50)                                                
      Compression                                      3 (6%)       5 (10%)      2 (4%)                                             
      Gliosis                                                                    1 (2%)                                             
      Hemorrhage                                       2 (4%)       2 (4%)                                                          
      Ventricle, Dilatation                                         1 (2%)                                                          
   Spinal Cord                                                                  (1)                                                 
      White Matter, Degeneration                                                 1 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (50)         (48)         (48)                                                
      Foreign Body                                                  1 (2%)                                                          
      Inflammation, Suppurative                        3 (6%)       5 (10%)                                                         
      Epithelium, Hyperplasia                                       1 (2%)                                                          
   Lung                                               (49)         (50)         (49)                                                
      Foreign Body                                     1 (2%)       1 (2%)       1 (2%)                                             
      Hemorrhage                                       2 (4%)                                                                       
      Inflammation, Granulomatous                      3 (6%)       7 (14%)      3 (6%)                                             
      Leukocytosis                                     1 (2%)                                                                       
      Thrombosis                                       2 (4%)                                                                       
      Alveolar Epithelium, Hyperplasia                 4 (8%)      14 (28%)     14 (29%)                                            
      Alveolus, Fibrosis                               1 (2%)       2 (4%)       2 (4%)                                             
      Alveolus, Infiltration Cellular, Histiocyte     21 (43%)     41 (82%)     31 (63%)                                            
      Alveolus, Inflammation, Suppurative             13 (27%)      5 (10%)      4 (8%)                                             
      Artery, Inflammation                                                       1 (2%)                                             
      Artery, Mineralization                          20 (41%)     16 (32%)     15 (31%)                                            
      Bronchiole, Hyperplasia                                                    1 (2%)                                             
      Pleura, Inflammation, Chronic                                              1 (2%)                                             
   Nose                                               (49)         (48)         (47)                                                
      Inflammation, Suppurative                        5 (10%)      7 (15%)     11 (23%)                                            
      Glands, Dilatation                               9 (18%)     29 (60%)     39 (83%)                                            
      Nasolacrimal Duct, Inflammation, Suppurative     4 (8%)       1 (2%)                                                          
      Olfactory Epithelium, Degeneration                           46 (96%)     47 (100%)                                           
      Olfactory Epithelium, Metaplasia                              4 (8%)       6 (13%)                                            
      Olfactory Epithelium, Metaplasia, Squamous                    9 (19%)     31 (66%)                                            
      Respiratory Epithelium, Dysplasia                                          1 (2%)                                             
      Respiratory Epithelium, Hyperplasia              1 (2%)      18 (38%)     22 (47%)                                            
      Respiratory Epithelium, Metaplasia, Squamous                 37 (77%)     38 (81%)                                            
   Trachea                                            (49)         (49)         (48)                                                
      Inflammation, Suppurative                        2 (4%)       1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Glands, Dilatation                               1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS FEMALE                CONTROL      5 PPM        10 PPM                                                 
                                                   FEMALE       FEMALE       FEMALE                                                 
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                             (3)                                                              
      Cataract, Multiple                                            1 (33%)                                                         
   Lacrimal Gland                                     (5)          (1)          (2)                                                 
      Hyperplasia                                                   1 (100%)                                                        
      Inflammation, Chronic                            3 (60%)      1 (100%)     2 (100%)                                           
      Inflammation, Suppurative                        1 (20%)                                                                      
      Karyomegaly                                      4 (80%)      1 (100%)     2 (100%)                                           
      Necrosis                                         1 (20%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (48)         (49)                                                
      Cyst                                                          1 (2%)       3 (6%)                                             
      Nephropathy, Chronic                            48 (96%)     42 (88%)     46 (94%)                                            
      Pelvis, Dilatation                               1 (2%)                                                                       
      Pelvis, Hyperplasia                              3 (6%)       3 (6%)       2 (4%)                                             
      Pelvis, Mineralization                          15 (30%)     15 (31%)     15 (31%)                                            
      Renal Tubule, Degeneration                                    1 (2%)                                                          
      Renal Tubule, Mineralization                    14 (28%)     18 (38%)     11 (22%)                                            
   Urinary Bladder                                    (49)         (47)         (47)                                                
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia                                      1 (2%)       1 (2%)                                                          
      Inflammation, Suppurative                                     1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS MALE                  CONTROL      5 PPM        10 PPM                                                 
                                                   MALE         MALE         MALE                                                   
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          50           50           50                                                  
  Early Deaths                                                                                                                      
    Dead                                              27           27           29                                                  
    Moribund                                          11           12           13                                                  
  Survivors                                                                                                                         
    Moribund                                                        1                                                               
    Terminal Sacrifice                                12           10            8                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (23)         (21)         (15)                                                
      Parasite Metazoan                                2 (9%)       1 (5%)       2 (13%)                                            
      Artery, Inflammation                                                       1 (7%)                                             
   Intestine Large, Colon                             (39)         (38)         (34)                                                
      Parasite Metazoan                                4 (10%)      3 (8%)       4 (12%)                                            
   Intestine Large, Rectum                            (40)         (42)         (38)                                                
      Parasite Metazoan                                4 (10%)      2 (5%)                                                          
      Artery, Inflammation                                          2 (5%)                                                          
   Intestine Small, Ileum                             (24)         (27)         (23)                                                
      Artery, Inflammation                                                       1 (4%)                                             
   Liver                                              (49)         (49)         (47)                                                
      Angiectasis                                      1 (2%)       1 (2%)       2 (4%)                                             
      Basophilic Focus                                 1 (2%)       1 (2%)                                                          
      Clear Cell Focus                                 1 (2%)       4 (8%)       3 (6%)                                             
      Developmental Malformation                       1 (2%)                                                                       
      Hematopoietic Cell Proliferation                 1 (2%)       2 (4%)       1 (2%)                                             
      Inflammation, Granulomatous                      3 (6%)                                                                       
      Inflammation, Suppurative                                     1 (2%)                                                          
      Necrosis                                                      3 (6%)       2 (4%)                                             
      Bile Duct, Cyst                                                            1 (2%)                                             
      Bile Duct, Fibrosis                              1 (2%)       2 (4%)       6 (13%)                                            
      Bile Duct, Hyperplasia                                        1 (2%)       2 (4%)                                             
   Mesentery                                          (1)                       (1)                                                 
      Inflammation                                     1 (100%)                                                                     
      Artery, Inflammation                                                       1 (100%)                                           
   Pancreas                                           (48)         (48)         (44)                                                
      Atrophy                                          2 (4%)       6 (13%)      2 (5%)                                             
      Fibrosis                                                                   1 (2%)                                             
      Hemorrhage                                                                 1 (2%)                                             
      Infarct                                                                    1 (2%)                                             
      Inflammation, Chronic                                         1 (2%)                                                          
      Inflammation, Suppurative                                     1 (2%)                                                          
      Acinus, Hyperplasia                              1 (2%)       1 (2%)       2 (5%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS MALE                  CONTROL      5 PPM        10 PPM                                                 
                                                   MALE         MALE         MALE                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Artery, Inflammation                             6 (13%)      7 (15%)      9 (20%)                                            
      Artery, Thrombosis                                                         1 (2%)                                             
   Salivary Glands                                    (50)         (46)         (47)                                                
      Cyst                                                          1 (2%)                                                          
      Inflammation, Chronic                           12 (24%)      6 (13%)      5 (11%)                                            
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Inflammation, Suppurative                        2 (4%)                                                                       
      Karyomegaly                                     21 (42%)     23 (50%)     20 (43%)                                            
   Stomach                                            (48)         (49)         (46)                                                
      Artery, Inflammation                             1 (2%)       1 (2%)                                                          
   Stomach, Forestomach                               (45)         (43)         (44)                                                
      Acanthosis                                                    2 (5%)                                                          
      Hyperkeratosis                                                             1 (2%)                                             
      Inflammation, Suppurative                        1 (2%)                    1 (2%)                                             
   Stomach, Glandular                                 (48)         (48)         (46)                                                
      Cyst                                                                       1 (2%)                                             
      Developmental Malformation                                    1 (2%)                                                          
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia                                                                1 (2%)                                             
      Inflammation, Necrotizing                                                  1 (2%)                                             
      Mineralization                                   4 (8%)       1 (2%)       1 (2%)                                             
      Necrosis                                                      1 (2%)       1 (2%)                                             
      Artery, Inflammation                             2 (4%)                    1 (2%)                                             
   Tongue                                             (2)                                                                           
      Hyperplasia, Squamous                            1 (50%)                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)                                                
      Cardiomyopathy                                  12 (24%)     12 (24%)     19 (38%)                                            
      Inflammation, Suppurative                                                  2 (4%)                                             
      Aortic Valve, Mineralization                     2 (4%)                                                                       
      Artery, Inflammation                             2 (4%)       1 (2%)       1 (2%)                                             
      Artery, Mineralization                           7 (14%)      2 (4%)       2 (4%)                                             
      Atrium, Mineralization                           1 (2%)                                                                       
      Atrium, Thrombosis                               8 (16%)      3 (6%)       8 (16%)                                            
      Endocardium, Fibrosis                                         1 (2%)       1 (2%)                                             
      Myocardium, Hemorrhage                                                     1 (2%)                                             
      Ventricle, Mineralization                        1 (2%)                                                                       
      Ventricle, Thrombosis                                                      1 (2%)                                             
      Ventricle Right, Dilatation                                                1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS MALE                  CONTROL      5 PPM        10 PPM                                                 
                                                   MALE         MALE         MALE                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (48)         (48)         (48)                                                
      Angiectasis                                                   1 (2%)                                                          
      Hemorrhage                                       1 (2%)                                                                       
      Hyperplasia                                      8 (17%)     15 (31%)     13 (27%)                                            
      Hypertrophy                                                                1 (2%)                                             
      Infarct                                                                    1 (2%)                                             
      Inflammation, Chronic                                         1 (2%)                                                          
      Mineralization                                                1 (2%)                                                          
      Necrosis                                                      1 (2%)       1 (2%)                                             
      Vacuolization Cytoplasmic                       10 (21%)     14 (29%)     17 (35%)                                            
   Adrenal Gland, Medulla                             (47)         (47)         (47)                                                
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia                                     10 (21%)     11 (23%)     10 (21%)                                            
      Hyperplasia, Multiple                            1 (2%)                                                                       
      Mineralization                                   1 (2%)                                                                       
   Islets, Pancreatic                                 (48)         (48)         (45)                                                
      Hyperplasia                                                   1 (2%)       1 (2%)                                             
   Parathyroid Gland                                  (36)         (30)         (38)                                                
      Hyperplasia                                      2 (6%)       1 (3%)       1 (3%)                                             
      Hyperplasia, Multiple                                         1 (3%)                                                          
   Pituitary Gland                                    (47)         (46)         (44)                                                
      Pars Distalis, Cyst                              2 (4%)       3 (7%)       3 (7%)                                             
      Pars Distalis, Hyperplasia                       2 (4%)       2 (4%)       4 (9%)                                             
      Pars Intermedia, Hyperplasia                                               1 (2%)                                             
   Thyroid Gland                                      (43)         (46)         (46)                                                
      Inflammation, Chronic                            1 (2%)                                                                       
      Ultimobranchial Cyst                             4 (9%)       2 (4%)       3 (7%)                                             
      C-Cell, Hyperplasia                             10 (23%)      7 (15%)      7 (15%)                                            
      Follicular Cell, Hyperplasia                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (43)         (42)         (42)                                                
      Artery, Inflammation                             1 (2%)                                                                       
   Preputial Gland                                    (49)         (48)         (46)                                                
      Cyst                                             7 (14%)      2 (4%)       2 (4%)                                             
      Hyperplasia                                                                1 (2%)                                             
      Inflammation, Suppurative                       22 (45%)     23 (48%)     15 (33%)                                            
   Prostate                                           (49)         (49)         (46)                                                
      Cyst                                                          1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS MALE                  CONTROL      5 PPM        10 PPM                                                 
                                                   MALE         MALE         MALE                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Inflammation, Suppurative                        3 (6%)       4 (8%)       4 (9%)                                             
      Mineralization                                                             1 (2%)                                             
      Artery, Inflammation                                                       1 (2%)                                             
      Epithelium, Hyperplasia                                                    1 (2%)                                             
   Seminal Vesicle                                    (49)         (49)         (45)                                                
      Inflammation, Suppurative                        3 (6%)       2 (4%)       4 (9%)                                             
      Artery, Inflammation                             1 (2%)                    1 (2%)                                             
   Testes                                             (49)         (49)         (49)                                                
      Infarct                                                                    1 (2%)                                             
      Mineralization                                   1 (2%)       6 (12%)      7 (14%)                                            
      Artery, Inflammation                            10 (20%)     10 (20%)     11 (22%)                                            
      Seminiferous Tubule, Atrophy                     7 (14%)      6 (12%)      3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (46)         (48)         (44)                                                
      Fibrosis                                                                   1 (2%)                                             
   Lymph Node                                         (48)         (44)         (45)                                                
      Fibrosis                                                      1 (2%)                                                          
      Hyperplasia, Lymphoid                            1 (2%)                                                                       
      Mediastinal, Hemorrhage                                       1 (2%)                                                          
      Renal, Hemorrhage                                3 (6%)                                                                       
   Lymph Node, Bronchial                              (40)         (29)         (38)                                                
      Hemorrhage                                       5 (13%)                   6 (16%)                                            
      Inflammation, Granulomatous                                   1 (3%)                                                          
   Lymph Node, Mandibular                             (44)         (40)         (42)                                                
      Hemorrhage                                       2 (5%)                    3 (7%)                                             
      Hyperplasia, Lymphoid                            1 (2%)       1 (3%)       2 (5%)                                             
      Infiltration Cellular, Histiocyte                1 (2%)                                                                       
      Inflammation, Chronic                            1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)                    2 (5%)                                             
   Spleen                                             (50)         (49)         (46)                                                
      Hematopoietic Cell Proliferation                              4 (8%)       1 (2%)                                             
      Hemorrhage                                                    2 (4%)                                                          
      Infarct                                                       1 (2%)       1 (2%)                                             
   Thymus                                             (46)         (46)         (44)                                                
      Hemorrhage                                                                 2 (5%)                                             
      Thrombosis                                                                 1 (2%)                                             
      Artery, Inflammation                             1 (2%)                    2 (5%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS MALE                  CONTROL      5 PPM        10 PPM                                                 
                                                   MALE         MALE         MALE                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (49)         (49)         (49)                                                
      Giant Cell                                       1 (2%)                                                                       
      Granuloma                                        1 (2%)                                                                       
      Inflammation, Suppurative                                     1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (49)                                                
      Osteoporosis                                                               1 (2%)                                             
   Skeletal Muscle                                    (1)          (1)                                                              
      Laryngeal, Degeneration                          1 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)                                                
      Compression                                      1 (2%)       1 (2%)                                                          
      Demyelination                                    1 (2%)                                                                       
      Gliosis                                                       1 (2%)                                                          
      Hemorrhage                                       4 (8%)       2 (4%)       3 (6%)                                             
      Necrosis                                                                   1 (2%)                                             
      Thrombosis                                       1 (2%)                                                                       
      Ventricle, Dilatation                            1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Larynx                                             (39)         (45)         (43)                                                
      Inflammation, Chronic                            2 (5%)                    2 (5%)                                             
      Inflammation, Suppurative                                     1 (2%)       2 (5%)                                             
      Artery, Inflammation                                                       1 (2%)                                             
      Epithelium, Hyperplasia                                                    2 (5%)                                             
   Lung                                               (42)         (48)         (45)                                                
      Foreign Body                                     1 (2%)       1 (2%)                                                          
      Hemorrhage                                       7 (17%)      7 (15%)      8 (18%)                                            
      Inflammation, Granulomatous                      5 (12%)      3 (6%)       2 (4%)                                             
      Leukocytosis                                                  1 (2%)                                                          
      Alveolar Epithelium, Hyperplasia                 2 (5%)       6 (13%)      5 (11%)                                            
      Alveolus, Edema                                  1 (2%)       2 (4%)       2 (4%)                                             
      Alveolus, Fibrosis                               2 (5%)       4 (8%)       2 (4%)                                             
      Alveolus, Infiltration Cellular, Histiocyte      7 (17%)     17 (35%)     19 (42%)                                            
      Alveolus, Inflammation, Suppurative              6 (14%)      5 (10%)      7 (16%)                                            
      Alveolus, Mineralization                                                   1 (2%)                                             
      Artery, Inflammation                             7 (17%)     12 (25%)      6 (13%)                                            
      Artery, Mineralization                          18 (43%)     22 (46%)     16 (36%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS MALE                  CONTROL      5 PPM        10 PPM                                                 
                                                   MALE         MALE         MALE                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Bronchiole, Infiltration Cellular, Histiocyte                 1 (2%)                                                          
      Bronchiole, Inflammation, Suppurative            1 (2%)       1 (2%)       1 (2%)                                             
   Nose                                               (44)         (46)         (43)                                                
      Foreign Body                                     1 (2%)       3 (7%)       1 (2%)                                             
      Inflammation, Suppurative                        9 (20%)     27 (59%)     18 (42%)                                            
      Inflammation, Membranous                         3 (7%)       4 (9%)       7 (16%)                                            
      Glands, Dilatation                               8 (18%)     20 (43%)     21 (49%)                                            
      Nasolacrimal Duct, Inflammation, Suppurative     7 (16%)      3 (7%)       9 (21%)                                            
      Olfactory Epithelium, Degeneration                           45 (98%)     43 (100%)                                           
      Olfactory Epithelium, Metaplasia                              6 (13%)      9 (21%)                                            
      Olfactory Epithelium, Metaplasia, Squamous                   19 (41%)     35 (81%)                                            
      Respiratory Epithelium, Hyperplasia              4 (9%)      33 (72%)     30 (70%)                                            
      Respiratory Epithelium, Metaplasia, Squamous     4 (9%)      40 (87%)     38 (88%)                                            
   Trachea                                            (40)         (45)         (42)                                                
      Inflammation, Chronic                                                      2 (5%)                                             
      Inflammation, Suppurative                        1 (3%)                                                                       
      Artery, Inflammation                                                       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (2)          (1)          (2)                                                 
      Cataract                                                                   1 (50%)                                            
   Harderian Gland                                    (3)          (2)          (8)                                                 
      Hyperplasia                                      2 (67%)                                                                      
      Inflammation, Chronic                            1 (33%)                   8 (100%)                                           
      Karyomegaly                                                                7 (88%)                                            
   Lacrimal Gland                                     (19)         (21)         (7)                                                 
      Hyperplasia                                                                1 (14%)                                            
      Inflammation, Chronic                           19 (100%)    21 (100%)     7 (100%)                                           
      Inflammation, Suppurative                                     1 (5%)                                                          
      Karyomegaly                                     19 (100%)    21 (100%)     7 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (49)         (48)                                                
      Cyst                                             1 (2%)       1 (2%)       2 (4%)                                             
      Hemorrhage                                       1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)                                                                       
      Nephropathy, Chronic                            49 (98%)     49 (100%)    47 (98%)                                            
      Artery, Mineralization                           1 (2%)                                                                       
      Glomerulus, Mineralization                                                 1 (2%)                                             
      Pelvis, Hemorrhage                                            1 (2%)                                                          
      Pelvis, Hyperplasia                              2 (4%)       2 (4%)       2 (4%)                                             
      Pelvis, Inflammation, Suppurative                             2 (4%)       3 (6%)                                             
      Pelvis, Mineralization                           3 (6%)       3 (6%)       2 (4%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   13                                                              
NTP Experiment-Test: 05080-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                        ALLYL GLYCIDYL ETHER                                   Date: 09/10/94  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 18:51:04  
____________________________________________________________________________________________________________________________________
         OSBORNE MENDEL RATS MALE                  CONTROL      5 PPM        10 PPM                                                 
                                                   MALE         MALE         MALE                                                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Renal Tubule, Mineralization                     2 (4%)                    1 (2%)                                             
   Urinary Bladder                                    (46)         (49)         (44)                                                
      Calculus Gross Observation                       2 (4%)                                                                       
      Calculus Micro Observation Only                  3 (7%)                                                                       
      Hemorrhage                                                                 1 (2%)                                             
      Hyperplasia                                      2 (4%)       1 (2%)       3 (7%)                                             
      Inflammation, Chronic                            1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)       2 (4%)       4 (9%)                                             
      Artery, Inflammation                                          1 (2%)                                                          
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   14                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 91578-91578/91578


--multipart-boundary--